Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 2 Efficacy and Safety Study of LY2484595 Alone and in Combination With Atorvastatin, Simvastatin, and Rosuvastatin in Patients With Hypercholesterolemia or Low HDL-C
Brief Summary: The primary purpose of your participation in this study is to help answer the following research question(s)

* Whether LY2484595 in combination with a statin drug (atorvastatin, simvastatin or rosuvastatin; currently used to treat abnormal fat or cholesterol in blood) improves the blood fat profile more than statins alone.
* Whether LY2484595 alone improves blood fats profile compared to sugar pills.
* Whether LY2484595 interferes with break down or functioning of statins.
* Whether LY2484595 has any side effects that would not support testing it in future studies.


Options:
A: Arm Label: 30 milligram (mg) LY2484595 monotherapy; Type: EXPERIMENTAL; Interventions: Drug: LY2484595, Drug: Placebo for Statins | Arm Label: 100 mg LY2484595 monotherapy; Type: EXPERIMENTAL; Interventions: Drug: LY2484595, Drug: Placebo for Statins | Arm Label: 500 mg LY2484595 monotherapy; Type: EXPERIMENTAL; Interventions: Drug: LY2484595, Drug: Placebo for Statins | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo for LY2484595, Drug: Placebo for Statins | Arm Label: 20 mg Atorvastatin monotherapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atorvastatin, Drug: Placebo for LY2484595 | Arm Label: 100 mg LY2484595 + 20 mg Atorvastatin; Type: EXPERIMENTAL; Interventions: Drug: LY2484595, Drug: Atorvastatin | Arm Label: 40 mg Simvastatin monotherapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Simvastatin, Drug: Placebo for LY2484595 | Arm Label: 100 mg LY2484595 + 40 mg Simvastatin; Type: EXPERIMENTAL; Interventions: Drug: LY2484595, Drug: Simvastatin | Arm Label: 10 mg Rosuvastatin monotherapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Rosuvastatin, Drug: Placebo for LY2484595 | Arm Label: 100 mg LY2484595 + 10 mg Rosuvastatin; Type: EXPERIMENTAL; Interventions: Drug: LY2484595, Drug: Rosuvastatin | Intervention Type: DRUG; Name: LY2484595; Assigned to Arm(s): 100 mg LY2484595 + 10 mg Rosuvastatin, 100 mg LY2484595 + 20 mg Atorvastatin, 100 mg LY2484595 + 40 mg Simvastatin, 100 mg LY2484595 monotherapy, 30 milligram (mg) LY2484595 monotherapy, 500 mg LY2484595 monotherapy | Intervention Type: DRUG; Name: Atorvastatin; Assigned to Arm(s): 100 mg LY2484595 + 20 mg Atorvastatin, 20 mg Atorvastatin monotherapy | Intervention Type: DRUG; Name: Simvastatin; Assigned to Arm(s): 100 mg LY2484595 + 40 mg Simvastatin, 40 mg Simvastatin monotherapy | Intervention Type: DRUG; Name: Rosuvastatin; Assigned to Arm(s): 10 mg Rosuvastatin monotherapy, 100 mg LY2484595 + 10 mg Rosuvastatin | Intervention Type: DRUG; Name: Placebo for LY2484595; Assigned to Arm(s): 10 mg Rosuvastatin monotherapy, 20 mg Atorvastatin monotherapy, 40 mg Simvastatin monotherapy, Placebo | Intervention Type: DRUG; Name: Placebo for Statins; Assigned to Arm(s): 100 mg LY2484595 monotherapy, 30 milligram (mg) LY2484595 monotherapy, 500 mg LY2484595 monotherapy, Placebo
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Atorvastatin | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Atorvastatin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
C: Intervention Type: DRUG; Name: Atorvastatin; Assigned to Arm(s): N/A
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Atorvastatin; Type: EXPERIMENTAL; Interventions: Drug: Atorvastatin | Intervention Type: DRUG; Name: Atorvastatin; Assigned to Arm(s): Atorvastatin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A